Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Free Cash Flow (2016 - 2026)

Iradimed has reported Free Cash Flow over the past 14 years, most recently at $7.9 million for Q1 2026.

  • Quarterly Free Cash Flow rose 1225.55% to $7.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $31.6 million through Mar 2026, up 116.3% year-over-year, with the annual reading at $24.3 million for FY2025, 37.87% up from the prior year.
  • Free Cash Flow was $7.9 million for Q1 2026 at Iradimed, down from $12.7 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $12.7 million in Q4 2025 and troughed at -$1.7 million in Q1 2023.
  • The 5-year median for Free Cash Flow is $3.6 million (2024), against an average of $4.2 million.
  • Year-over-year, Free Cash Flow plummeted 240.79% in 2023 and then soared 1225.55% in 2026.
  • A 5-year view of Free Cash Flow shows it stood at $2.8 million in 2022, then surged by 34.91% to $3.8 million in 2023, then decreased by 16.14% to $3.2 million in 2024, then surged by 298.48% to $12.7 million in 2025, then tumbled by 38.08% to $7.9 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Free Cash Flow are $7.9 million (Q1 2026), $12.7 million (Q4 2025), and $5.8 million (Q3 2025).